Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)
NCT06911619 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210
Last updated 2025-07-04
Summary
Cirrhosis is a major public health issue responsible for about 15000 deaths each year. Liver transplantation (LT) remains the only curative treatment for decompensated cirrhosis. Decompensated cirrhotic patients awaiting LT are malnourished, sarcopenic and fragile. The evaluation of the nutritional status of these patients is complex because the anthropometric data that define undernutrition (weight variation, BMI) are often compromised by the presence of edema and ascites related to liver disease. It therefore seems appropriate to focus on the fragility and sarcopenia of the cirrhotic patient as a reflection of the nutritional status. In 2017, the American team of Lai et al. validated a Liver fraily index (LFI) score of frailty specific to cirrhotic patients waiting for LT. The LFI is composed of three simple physical tests (Grip test, chair lift test, and balance tests) performed at the patient's bedside, which results in a quantitative and reproducible frailty score. Frailty while waiting for LT is associated with an increase in mortality on the waiting list, independently of the MELD (Model for End stage Liver disease) score, which is a reflection of liver severity. About half of the patients who are candidates for LT will present an aggravation of their frailty while waiting for LT. To date, no study has reported the results of a nutritional intervention on the evolution of fragility in patients awaiting LT. The objective of our study is to evaluate the impact of a nutritional management and follow-up by a dietitian specialized in hepatology on the fragility of patients waiting for LT. This is a monocentric study, randomized in two parallel groups (an intervention group with nutritional follow-ups by a trained dietitian and a control group with follow-up by the reference hepatologist without specific dietary management by a dietician) in open. All patients enrolled on the LT list with an LFI \> 3.2 (pre-frail and frail state) will be included in the study. It is planned to include 210 patients over a period of 24 months. The LFI will be measured for all patients (control group + intervention group) at 3 and 6 months, as part of their follow-up in the LT center. This study will also make it possible to correlate frailty with other parameters (severity of liver disease, access to LT).
Conditions
- Fragility
- Cirrhosis
- Hepatic Transplantation
- Undernutrition
Interventions
- DIETARY_SUPPLEMENT
-
Dietary management
The intervention consists of a personalized dietary management with a nutritional follow-up pending transplantation. Teleconsultation appointments are scheduled with the dietician for dietary coaching and a re-evaluation of the nutritional strategy every month. Follow-up visits in person, carried out by the dietitian at the 3rd and 6th month waiting for transplant and are coupled with the usual consultations with the referring hepatologist. The visits allow the realization of LFI (Liver Frailty Index), the collection of interrelated events and the reassessment of hepatic disease as well as the re-evaluation of the nutritional strategy (CNO, enteral or parenteral nutrition)
- OTHER
-
No dietary management
The patient will be followed up by his reference hepatologist every 3 months. Follow-up visits at 3 months and 6 months waiting for liver transplantation will be performed by Clinical Research assistant on the same day as the follow-up consultation with his hepatologist with the completion of the Liver Frailty Index test and the collection of intercurrent events and the reassessment of liver disease.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
Maxime PATUREL · Service Rééducation Nutritionnelle Hôpital de la Croix Rousse / GHN
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-30
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-30
Countries
- France
Study Locations
More Related Trials
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921 ·Status: RECRUITING
-
Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study
NCT06948565 ·Status: RECRUITING
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
Characterization of the Nutritional Status in the Patient With Liver Cirrhosis
NCT04073693 ·Status: COMPLETED ·Phase: NA
-
Infections in Hospitalized Cirrhotic Patients
NCT03137719 ·Status: COMPLETED
-
Mechanism of TIPS to Improve Sarcopenia
NCT06794853 ·Status: RECRUITING
-
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
NCT06328517 ·Status: RECRUITING
-
Fecal Microbiota Transplantation in Decompensated Cirrhosis
NCT04842539 ·Status: COMPLETED ·Phase: NA
-
Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
NCT06814626 ·Status: RECRUITING ·Phase: PHASE3
-
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
NCT03871894 ·Status: COMPLETED ·Phase: NA
-
Prognosis of Patients With Acute-on-chronic Liver Failure
NCT05393453 ·Status: UNKNOWN
-
Bioelectrical Impedance Vector Analysis in Cirrhotic Patients
NCT01603953 ·Status: COMPLETED
-
Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis
NCT00701792 ·Status: COMPLETED ·Phase: NA
-
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
NCT06263816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
NCT05011370 ·Status: COMPLETED
-
Nutritional Assessment in Individuals with Liver Cirrhosis
NCT06588712 ·Status: NOT_YET_RECRUITING
-
Study of microRNAs in a Decompensated Cirrhosis
NCT03905746 ·Status: RECRUITING
-
Nutritional Assesment in Patients With Cirrhosis
NCT05729438 ·Status: RECRUITING
-
Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease
NCT02140294 ·Status: COMPLETED ·Phase: NA
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Phase Angle and Mortality in Patients With Cirrhosis
NCT02023177 ·Status: COMPLETED
-
Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis
NCT05033327 ·Status: COMPLETED ·Phase: NA
-
Microbiome and Sarcopenia in Patients With Liver Cirrhosis
NCT03080129 ·Status: RECRUITING ·Phase: NA
-
Comparison of Nutritional Screening Tools in Liver Cirrhosis Patients
NCT04502719 ·Status: RECRUITING
-
To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
NCT07270809 ·Status: NOT_YET_RECRUITING